First Republic Investment Management Inc. increased its position in Neurotrope Inc (NASDAQ:NTRP) by 100.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 60,000 shares of the company’s stock after buying an additional 30,000 shares during the quarter. First Republic Investment Management Inc. owned about 0.76% of Neurotrope worth $310,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Stifel Financial Corp lifted its holdings in shares of Neurotrope by 273.8% in the second quarter. Stifel Financial Corp now owns 110,000 shares of the company’s stock valued at $1,031,000 after buying an additional 80,572 shares during the period. Cannell Peter B & Co. Inc. lifted its holdings in shares of Neurotrope by 20.8% in the third quarter. Cannell Peter B & Co. Inc. now owns 150,793 shares of the company’s stock valued at $778,000 after buying an additional 26,000 shares during the period. Dimensional Fund Advisors LP acquired a new stake in shares of Neurotrope in the second quarter valued at $445,000. Oaktop Capital Management II L.P. acquired a new stake in shares of Neurotrope in the second quarter valued at $1,095,000. Finally, Virtu KCG Holdings LLC acquired a new stake in shares of Neurotrope in the second quarter valued at $227,000. Institutional investors and hedge funds own 12.93% of the company’s stock.
Separately, ValuEngine upgraded Neurotrope from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st.
Neurotrope, Inc, formerly BlueFlash Communications, Inc, is a biopharmaceutical company with its product candidates in pre-clinical and clinical development. The Company is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer’s disease (AD), which is in the clinical testing stage.
Want to see what other hedge funds are holding NTRP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neurotrope Inc (NASDAQ:NTRP).
Receive News & Ratings for Neurotrope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neurotrope and related companies with MarketBeat.com's FREE daily email newsletter.